Pfizer to Withdraw Cancer Drug Mylotarg

more+
less-

The Food and Drug Administration said Monday Pfizer Inc. is withdrawing its cancer drug Mylotarg from the U.S. market after a clinical study showed the drug wasn’t effective and had more safety problems.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.